amiodarone has been researched along with Cardiac Complex, Premature in 82 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although amiodarone was effective in suppressing ventricular arrhythmias and improving ventricular function, it did not reduce the incidence of sudden death or prolong survival among patients with heart failure, except for a trend toward reduced mortality among those with nonischemic cardiomyopathy." | 9.08 | Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. ( Colling, C; Deedwania, PC; Fisher, SG; Fletcher, RD; Lazzeri, D; Lewis, HD; Massie, BM; Singh, BN; Singh, SN, 1995) |
| "A randomized trial was conducted to assess the efficacy of amiodarone versus metoprolol or no antiarrhythmic treatment to suppress asymptomatic ectopic activity and improve survival in patients who have had myocardial infarction with a left ventricular ejection fraction of 20 to 45% and > or = 3 ventricular premature complexes per hour (pairs or runs)." | 9.07 | Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. ( Bayes de Luna, A; Cosin, J; Guindo, J; Marrugat, J; Navarro-López, F, 1993) |
| "The prophylactic administration of amiodarone following acute myocardial infarction has been investigated in several small trials." | 8.78 | Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis. ( Caruso, AC; Nolan, PE; Slack, MK; Zarembski, DG, 1993) |
| "Torsade de pointes, a polymorphous ventricular tachycardia, is a well-known but rarely occurring cardiac adverse drug reaction under amiodarone, a class-III antiarrhythmic agent." | 7.68 | [Torsade de pointes during anti-arrhythmia treatment with amiodarone]. ( Haefeli, WE; Lüscher, TF; Schlienger, RG, 1993) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| " The effectiveness of amiodarone and propafenone in treating ventricular arrhythmias was not significantly different." | 7.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "Antiarrhythmic effects of cordarone, ethacizine, and obsidan were evaluated in 30 patients with chronic alcoholism in whom premature ventricular contractions were recorded at a rate of at least of 5 per minute by 30-minute ECG monitoring when they were admitted to a narcologic hospital, having the alcohol withdrawal syndrome." | 7.68 | [Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal]. ( Gorgaslidze, AG; Karaush, AP; Smetnev, AS, 1991) |
| "A 52-year-old woman developed symmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of amiodarone treatment." | 7.67 | Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy. ( Abarbanel, JM; Frisher, S; Herishanu, Y; Osiman, A, 1987) |
| " To determine their relative antiarrhythmic efficacy, amiodarone and its desethyl metabolite, desethylamiodarone, were administered to mongrel dogs with ventricular tachycardia 24 hr after ligation of the left anterior descending coronary artery." | 7.67 | The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. ( Davies, M; Nattel, S; Quantz, M, 1988) |
| "A large spectrum of arrhythmias was encountered, and particular attention was paid to their relation with the autonomic nervous system." | 5.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 5.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 5.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
| "Although amiodarone was effective in suppressing ventricular arrhythmias and improving ventricular function, it did not reduce the incidence of sudden death or prolong survival among patients with heart failure, except for a trend toward reduced mortality among those with nonischemic cardiomyopathy." | 5.08 | Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. ( Colling, C; Deedwania, PC; Fisher, SG; Fletcher, RD; Lazzeri, D; Lewis, HD; Massie, BM; Singh, BN; Singh, SN, 1995) |
| "A randomized trial was conducted to assess the efficacy of amiodarone versus metoprolol or no antiarrhythmic treatment to suppress asymptomatic ectopic activity and improve survival in patients who have had myocardial infarction with a left ventricular ejection fraction of 20 to 45% and > or = 3 ventricular premature complexes per hour (pairs or runs)." | 5.07 | Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. ( Bayes de Luna, A; Cosin, J; Guindo, J; Marrugat, J; Navarro-López, F, 1993) |
| "The EMIAT is a randomized, double-blind trial versus placebo, designed to evaluate the efficacy of amiodarone in the prevention of total mortality in patients with left ventricular ejection fraction of under 40% after myocardial infarction." | 5.07 | [Amiodarone and secondary prevention. The EMIAT study]. ( Munoz, A, 1991) |
| "To examine the presence and time course of beta-adrenergic antagonism produced by amiodarone, the heart rate, QT interval and arrhythmia frequency in response to graded doses of isoproterenol were evaluated in eight patients treated with oral amiodarone for sustained ventricular tachycardia." | 5.06 | Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. ( Chen, RF; Kadish, AH; Morady, F; Schmaltz, S, 1990) |
| "Decades after its registration, amiodarone is still regarded as the most effective antiarrhythmic drug available for the treatment of tachyarrhythmias." | 4.86 | [Current role of amiodarone in antiarrhythmic therapy]. ( Sohns, C; Zabel, M, 2010) |
| "The prophylactic administration of amiodarone following acute myocardial infarction has been investigated in several small trials." | 4.78 | Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis. ( Caruso, AC; Nolan, PE; Slack, MK; Zarembski, DG, 1993) |
| "Torsade de pointes, a polymorphous ventricular tachycardia, is a well-known but rarely occurring cardiac adverse drug reaction under amiodarone, a class-III antiarrhythmic agent." | 3.68 | [Torsade de pointes during anti-arrhythmia treatment with amiodarone]. ( Haefeli, WE; Lüscher, TF; Schlienger, RG, 1993) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| " In patients refractory to amiodarone alone or to a combination with mexiletine, the combined treatment with amiodarone and class-I-C drugs such as flecainide and encainide prolongs the cycle length of ventricular tachycardia, but does not suppress induction of ventricular tachycardia during programmed stimulation." | 3.68 | [Combination anti-arrhythmic drug therapy]. ( Jung, W; Lüderitz, B; Manz, M, 1992) |
| " The effectiveness of amiodarone and propafenone in treating ventricular arrhythmias was not significantly different." | 3.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "Antiarrhythmic effects of cordarone, ethacizine, and obsidan were evaluated in 30 patients with chronic alcoholism in whom premature ventricular contractions were recorded at a rate of at least of 5 per minute by 30-minute ECG monitoring when they were admitted to a narcologic hospital, having the alcohol withdrawal syndrome." | 3.68 | [Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal]. ( Gorgaslidze, AG; Karaush, AP; Smetnev, AS, 1991) |
| " As the arrhythmia did not respond to any kind of therapy, amiodarone treatment was started, which the patient received in a maintenance dose of 600-400 mg/day for 4 years." | 3.68 | [Amidaron-induced dermatopathy resulting from unnecessary Cordarone therapy of ventricular parasystole]. ( Fazekas, T; Korom, I; Mágori, A; Pogátsa, G; Ungi, I, 1991) |
| " Individual differences between the longest and the shortest RV MAP durations indicate that: normally (40 subjects) ventricular repolarization is almost synchronous; QT prolongation due either to bradycardia or to amiodarone treatment (eight cases) may be the result of a uniform lengthening of ventricular repolarization, when ventricular arrhythmias are not present; in long QT syndromes (LQTSs) of differing etiology (10 cases), in which severe ventricular arrhythmias are present, marked individual differences in RV MAP duration are present and correspond with pathological asynchrony of ventricular repolarization." | 3.67 | Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. ( Bonatti, V; Botti, G; Rolli, A, 1985) |
| "A 52-year-old woman developed symmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of amiodarone treatment." | 3.67 | Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy. ( Abarbanel, JM; Frisher, S; Herishanu, Y; Osiman, A, 1987) |
| " To determine their relative antiarrhythmic efficacy, amiodarone and its desethyl metabolite, desethylamiodarone, were administered to mongrel dogs with ventricular tachycardia 24 hr after ligation of the left anterior descending coronary artery." | 3.67 | The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. ( Davies, M; Nattel, S; Quantz, M, 1988) |
| "amiodarone is an effective anti-arrhythmic drug, the effectiveness of which is based on a prolongation of the action potential and thus a lengthening of the refractory period." | 2.67 | [Amiodarone for long-term treatment of ventricular arrhythmias]. ( Müller, M; Wiedey, KD, 1991) |
| "Amiodarone was well tolerated and propafenone produced minor digestive and neurosensory troubles in about half the cases, only in one patient a more pronounced arrhythmogenic effect was observed." | 2.66 | [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole]. ( Cosnay, P; Fauchier, JP; Huguet, R; Moquet, B; Rouesnel, P; Wajman, A, 1986) |
| "The treatment of ventricular arrhythmias in the elderly population is a challenging problem." | 2.39 | Antiarrhythmic agents in older patients. Current state of knowledge. ( Akiyama, T; Daubert, JP; Kim, CH, 1994) |
| "Amiodarone was also more beneficial than individual antiarrhythmic therapy (mortality 10/100 patients, 10%)." | 2.38 | [What is the latest in anti-arrhythmia therapy?]. ( Gloor, HO, 1991) |
| "Neither the recurrence (38 vs 38%; p = 0." | 1.29 | Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease. ( Doyle, TK; Nasir, N; Pacifico, A; Wheeler, SH, 1994) |
| "Amiodarone proved to be an effective drug also for the long-term treatment of ventricular tachycardia, and possibly for the prevention of sudden cardiac death." | 1.28 | [Long-term treatment with amiodarone]. ( Baedeker, W; Barthel, P; Blömer, H; Goedel-Meinen, L; Hofmann, M; Schmidt, G, 1991) |
| "Amiodarone has been used for the last 20 years, initially as antianginal and then as antiarrhythmic agent." | 1.28 | [Optic neuropathy caused by amiodarone]. ( Ferreiro, JL; Isern Longares, JA; Ramón Moya, AF, 1990) |
| "Amiodarone was discontinued in all patients and corticosteroids were introduced in thirteen." | 1.28 | [Pneumonitis induced by amiodarone]. ( Cukier, A; Pileggi, F; Pinto, RM; Teixeira, LR; Terra Filho, M; Vargas, FS, 1989) |
| "The prevalence of ventricular arrhythmias was not different before and after the pacemaker implantation." | 1.27 | [Arrhythmia in patients with a DDD bicameral pacemaker]. ( Magnani, A; Occhetta, E; Perucca, A; Prando, MD; Rognoni, G; Rossi, L; Rossi, P, 1986) |
| "The ventricular extrasystole was greater than 90 VES/hour in 18 patients." | 1.27 | [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles]. ( Amiel, A; Badouraly, A; Boutaud, P; Demange, J; Gaudeau, B; Guillem, JP; Herpin, D; Tournadre, P, 1986) |
| "Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 1.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
| "Treatment with amiodarone resulted in a decrease in plasma T3 and free T3, an increase in plasma rT3, a marked diminution in the frequency of VPCs and a prolongation of the corrected QT interval (QTc)." | 1.27 | Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes. ( Biollaz, J; Goy, JJ; Lemarchand-Beraud, T; Magnenat, P; Nicod, P; Polikar, R; Schlapfer, J, 1986) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 1.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "The authors studied 13 cases of arrhythmia following pneumonectomy in a series of 94 pneumonectomies performed in the Thoracic Surgery Unit." | 1.27 | [Cardiac rhythm disorders after pneumonectomy]. ( Debesse, B; Dumouchel, A; Hubsch, JP; Zukerman, C, 1985) |
| "A large spectrum of arrhythmias was encountered, and particular attention was paid to their relation with the autonomic nervous system." | 1.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "Association of long QT with arrhythmia does not, therefore, invalidate the principle that homogeneously prolonged APD should be anti-arrhythmic." | 1.27 | Delayed ventricular repolarization as an anti-arrhythmic principle. ( Vaughan Williams, EM, 1985) |
| "The mechanisms underlying the cause of sudden death have not been clearly elucidated." | 1.27 | [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. ( Kleinebenne, A; McKenna, WJ, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (58.54) | 18.7374 |
| 1990's | 32 (39.02) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (2.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sohns, C | 1 |
| Zabel, M | 1 |
| Theisen, K | 1 |
| Jahrmärker, H | 1 |
| Kovaleva, LI | 2 |
| Paleev, NR | 2 |
| Vinogradova, TS | 1 |
| Nikiforova, TB | 2 |
| Kel'man, IM | 1 |
| Faniel, R | 1 |
| Friart, J | 1 |
| Tuna, JL | 1 |
| Correia, MJ | 1 |
| d'Almeida, VC | 1 |
| Mourão, L | 1 |
| da Costa, FL | 1 |
| Ribeiro, C | 1 |
| Zhivoderov, VM | 1 |
| Zakharov, VN | 2 |
| Doshchitsin, VL | 1 |
| Aksenova, TN | 1 |
| Andriukova, EI | 1 |
| Corbalán, R | 1 |
| Braun, S | 1 |
| Chamorro, G | 1 |
| Zegpi, M | 1 |
| Henneberger, K | 1 |
| Lüderitz, B | 2 |
| Korkushko, OV | 2 |
| Butenko, AG | 1 |
| Hesselmann, J | 1 |
| Huep, WW | 1 |
| Schröder, E | 1 |
| Anshelevich, IuV | 2 |
| Orlova, VP | 2 |
| Braun, VB | 1 |
| Dumesh, SZ | 1 |
| Gurvich, TR | 1 |
| Markov, KV | 1 |
| Sapozhnikov, AA | 1 |
| Kalvelis, AD | 1 |
| Rubin, AI | 1 |
| Sporan, VG | 1 |
| Coumel, P | 1 |
| Leclercq, JF | 1 |
| Assayag, P | 1 |
| Zarembski, DG | 1 |
| Nolan, PE | 1 |
| Slack, MK | 1 |
| Caruso, AC | 1 |
| Navarro-López, F | 1 |
| Cosin, J | 1 |
| Marrugat, J | 1 |
| Guindo, J | 1 |
| Bayes de Luna, A | 1 |
| Martínez-Rubio, A | 1 |
| Shenasa, M | 1 |
| Chen, X | 1 |
| Wichter, T | 1 |
| Breithardt, G | 1 |
| Borggrefe, M | 1 |
| Nasir, N | 1 |
| Doyle, TK | 1 |
| Wheeler, SH | 1 |
| Pacifico, A | 1 |
| Reshef, R | 1 |
| Cohen, I | 1 |
| Shiller, M | 1 |
| Szvalb, S | 1 |
| Loberant, N | 1 |
| Kim, CH | 1 |
| Daubert, JP | 1 |
| Akiyama, T | 1 |
| Mahmarian, JJ | 1 |
| Smart, FW | 1 |
| Moyé, LA | 1 |
| Young, JB | 1 |
| Francis, MJ | 1 |
| Kingry, CL | 1 |
| Verani, MS | 1 |
| Pratt, CM | 1 |
| Kurbanov, RD | 1 |
| Azimova, NA | 1 |
| Kiakbaev, GK | 1 |
| Abdullaev, TA | 1 |
| Asriiants, LS | 1 |
| Zakirov, NU | 1 |
| Avezov, DK | 1 |
| Faĭzullaev, BP | 1 |
| Cui, G | 1 |
| Sen, L | 1 |
| Sager, P | 1 |
| Uppal, P | 1 |
| Singh, BN | 3 |
| Singh, SN | 1 |
| Fletcher, RD | 2 |
| Fisher, SG | 1 |
| Lewis, HD | 1 |
| Deedwania, PC | 1 |
| Massie, BM | 1 |
| Colling, C | 1 |
| Lazzeri, D | 1 |
| Cairns, JA | 1 |
| Connolly, SJ | 1 |
| Roberts, R | 1 |
| Gent, M | 1 |
| Schlienger, RG | 1 |
| Haefeli, WE | 1 |
| Lüscher, TF | 1 |
| Curtis, AB | 1 |
| Iervasi, G | 1 |
| Clerico, A | 1 |
| Berti, S | 1 |
| Pilo, A | 1 |
| Biagini, A | 1 |
| Bianchi, R | 1 |
| Donato, L | 1 |
| Van Schepdael, J | 1 |
| Solvay, H | 1 |
| Kuznetsov, KK | 1 |
| Brochier, M | 1 |
| Fauchier, JP | 2 |
| Valensise, H | 1 |
| Civitella, C | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 1 |
| Jung, W | 1 |
| Manz, M | 1 |
| Singh, S | 1 |
| Fisher, S | 1 |
| Deedwania, P | 1 |
| Lewis, D | 1 |
| Massie, B | 1 |
| Singh, B | 1 |
| Colling, CL | 1 |
| Ventosa, A | 1 |
| Adragão, P | 1 |
| Bonhorst, D | 1 |
| Seabra-Gomes, R | 1 |
| Antiuf'ev, VF | 2 |
| Arkhipov, MV | 3 |
| Ferreiro, JL | 1 |
| Isern Longares, JA | 1 |
| Ramón Moya, AF | 1 |
| Kadish, AH | 1 |
| Chen, RF | 1 |
| Schmaltz, S | 1 |
| Morady, F | 1 |
| Shatilo, VB | 1 |
| Karaush, AP | 1 |
| Gorgaslidze, AG | 1 |
| Smetnev, AS | 1 |
| Baedeker, W | 2 |
| Goedel-Meinen, L | 2 |
| Schmidt, G | 2 |
| Hofmann, M | 2 |
| Barthel, P | 2 |
| Blömer, H | 2 |
| Maier-Rudolph, W | 1 |
| Schrag, A | 1 |
| Müller, M | 1 |
| Wiedey, KD | 1 |
| Shpektor, AV | 1 |
| Susliak, NN | 1 |
| Fazekas, T | 1 |
| Korom, I | 1 |
| Mágori, A | 1 |
| Pogátsa, G | 1 |
| Ungi, I | 1 |
| Gloor, HO | 1 |
| Munoz, A | 1 |
| Schmidt, SB | 1 |
| Katz, RJ | 1 |
| Zukerman, C | 1 |
| Hubsch, JP | 1 |
| Dumouchel, A | 1 |
| Debesse, B | 1 |
| Oleĭnikov, VE | 1 |
| Tatarchenko, IP | 1 |
| Zhivotovskaia, GG | 1 |
| Bonatti, V | 1 |
| Rolli, A | 1 |
| Botti, G | 1 |
| Vaughan Williams, EM | 1 |
| Tatti, V | 1 |
| Ramelli, G | 1 |
| Gaudeau, B | 1 |
| Badouraly, A | 1 |
| Herpin, D | 1 |
| Tournadre, P | 1 |
| Boutaud, P | 1 |
| Amiel, A | 1 |
| Guillem, JP | 1 |
| Demange, J | 1 |
| Kiseleva, LN | 1 |
| Nekrasova, LF | 1 |
| Best, JF | 1 |
| Rinkenberger, R | 1 |
| Lynch, L | 1 |
| Dunn, M | 1 |
| Polikar, R | 1 |
| Goy, JJ | 1 |
| Schlapfer, J | 1 |
| Lemarchand-Beraud, T | 1 |
| Biollaz, J | 1 |
| Magnenat, P | 1 |
| Nicod, P | 1 |
| Cosnay, P | 1 |
| Rouesnel, P | 1 |
| Moquet, B | 1 |
| Huguet, R | 1 |
| Wajman, A | 1 |
| Occhetta, E | 1 |
| Magnani, A | 1 |
| Prando, MD | 1 |
| Perucca, A | 1 |
| Rossi, L | 1 |
| Rognoni, G | 1 |
| Rossi, P | 1 |
| Gheri, RG | 1 |
| Marchi, F | 1 |
| Zambaldi, G | 1 |
| Multinu, D | 1 |
| Paladini, S | 1 |
| Fazzini, PF | 1 |
| Piwowarska, W | 1 |
| Sniezek-Maciejewska, M | 1 |
| Abarbanel, JM | 1 |
| Osiman, A | 1 |
| Frisher, S | 1 |
| Herishanu, Y | 1 |
| Nattel, S | 1 |
| Davies, M | 1 |
| Quantz, M | 1 |
| Cleland, JG | 1 |
| Dargie, HJ | 1 |
| Ford, I | 1 |
| Chang, HM | 1 |
| Hwang, YS | 1 |
| Wang, JL | 1 |
| Lai, HM | 1 |
| Miyauchi, E | 1 |
| Uchida, K | 1 |
| Yamamoto, I | 1 |
| Morimoto, S | 1 |
| Maeda, T | 1 |
| Miyamoto, M | 1 |
| Takekoshi, N | 1 |
| Murakami, E | 1 |
| Suárez Ortega, S | 1 |
| Franco Cebrián, J | 1 |
| Medina Fernández-Aceytuno, A | 1 |
| Armas Portela, M | 1 |
| Méndez Mora, D | 1 |
| Estévez Zarazaga, A | 1 |
| Tubman, R | 1 |
| Jenkins, J | 1 |
| Lim, J | 1 |
| Haberman, RJ | 1 |
| Ladenson, PW | 1 |
| Griffith, LS | 1 |
| Veltri, EP | 1 |
| Reĭngardene, DI | 2 |
| Bischoff, KH | 1 |
| Assmann, I | 1 |
| Dittrich, P | 1 |
| Meissner, C | 1 |
| Schwela, H | 1 |
| Antiu'fev, VF | 1 |
| Dobrotvorskaia, TE | 1 |
| Mustafaev, FM | 1 |
| Abdullaeva, TI | 1 |
| Matsueva, NL | 1 |
| Terra Filho, M | 1 |
| Vargas, FS | 1 |
| Cukier, A | 1 |
| Teixeira, LR | 1 |
| Pinto, RM | 1 |
| Pileggi, F | 1 |
| Banasiak, W | 1 |
| Telichowski, C | 1 |
| Molenda, W | 1 |
| Petruk, J | 1 |
| Metner, E | 1 |
| Góral, J | 1 |
| McKenna, WJ | 1 |
| Kleinebenne, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (CALYPSO) PILOT TRIAL[NCT01576042] | 27 participants (Actual) | Interventional | 2012-05-31 | Terminated (stopped due to Main objectives of the study were met; consensus among investigators that continuing the study would not add new information beyond that already learned.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Records participants hospitalized for VT during the study (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 7 |
Records participants who completed Month 3 Follow-Up Visit (NCT01576042)
Timeframe: 3 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 12 |
Records participants who completed Month 6 Follow-Up Visit (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 7 |
| Antiarrhythmic Medication | 10 |
Records participants who had at least one of the efficacy outcome measurement (including death, hospitalization due to VT) (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who received study randomized treatment during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who only received study treatment as randomized during the entire study (NCT01576042)
Timeframe: 6 month
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 6 |
| Antiarrhythmic Medication | 13 |
Records participants who received study treatment as randomized and later switched to other treatment arm during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 1 |
Days from the date of the first study treatment to the date of first ICD recurrent therapy for VT. (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | Days (Mean) |
|---|---|
| Catheter Ablation | 70.1 |
| Antiarrhythmic Medication | 78.7 |
6 reviews available for amiodarone and Cardiac Complex, Premature
| Article | Year |
|---|---|
[Current role of amiodarone in antiarrhythmic therapy].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Comple | 2010 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi | 1980 |
Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
Topics: Aged; Amiodarone; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Female; Humans; Male; Middle | 1993 |
Antiarrhythmic agents in older patients. Current state of knowledge.
Topics: Aged; Aging; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; | 1994 |
Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac C | 1990 |
[What is the latest in anti-arrhythmia therapy?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Tri | 1991 |
17 trials available for amiodarone and Cardiac Complex, Premature
| Article | Year |
|---|---|
Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
Topics: Amiodarone; Benzofurans; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Doub | 1980 |
Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death.
Topics: Aged; Amiodarone; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Female; Humans; Male; Metopr | 1993 |
Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.
Topics: Adult; Aged; Amiodarone; Cardiac Complexes, Premature; Chi-Square Distribution; Double-Blind Method; | 1994 |
[Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents].
Topics: Aconitine; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Heart Rate; Huma | 1993 |
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow- | 1994 |
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Topics: Actuarial Analysis; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sud | 1995 |
Normalization of peripheral thyroid hormone metabolism induced by successful chronic amiodarone treatment in patients with ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Cardiac Complexes | 1996 |
Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators.
Topics: Amiodarone; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Double-Blind Method; Dru | 1992 |
Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac C | 1990 |
Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Cardiac Complexes, Premature; D | 1990 |
[Comparison of the anti-arrhythmic effectiveness of ethacizine, ethmozine, cordarone, mexitil and ritmilen in elderly patients with ventricular extrasystole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Heart Ventricl | 1990 |
[Amiodarone for long-term treatment of ventricular arrhythmias].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Electrocardiography, Ambul | 1991 |
[Amiodarone and secondary prevention. The EMIAT study].
Topics: Amiodarone; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Double-Blind Method; Humans; Myoca | 1991 |
[Cordaron in the treatment of patients with paroxysmal rhythm disorders].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofur | 1986 |
[Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Pre | 1986 |
[Anti-arrhythmic effect of cordaron in patients with unstable stenocardia and myocardial infarction].
Topics: Adult; Aged; Amiodarone; Angina Pectoris; Angina, Unstable; Cardiac Complexes, Premature; Clinical T | 1989 |
[Characteristics of the effectiveness of long-term treatment of ventricular arrhythmia with amiodarone hydrochloride after its intravenous administration].
Topics: Administration, Oral; Amiodarone; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Hea | 1988 |
60 other studies available for amiodarone and Cardiac Complex, Premature
| Article | Year |
|---|---|
[A different person in 2 minutes].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antisocial Personality Disorder; Attitude of Health Perso | 2011 |
[Treatment of parasystole and the problems of diagnosis of parasystole of the interlinked type].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Diagn | 1980 |
[Recurrent ventricular tachycardia studied by Holter's method (author's transl)].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Heart V | 1980 |
[Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cardiac Complexes | 1981 |
[Effect of amiodarone on ventricular arrhythmias evaluated by serial exercise testing (author's transl)].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Exercise T | 1981 |
[Is the revival of amiodarone (cordarone) justified? Testing of its anti-arrhythmic effect with long-term (24 hrs.) electrocardiography].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Electrocar | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
[Characteristics of action and efficacy of cordarone in permanent auricular fibrillation and extrasystole in elderly and aged patients].
Topics: Age Factors; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Premature; Hemod | 1983 |
[Life threatening alveolitis and hemolysis following amiodarone].
Topics: Amiodarone; Anemia, Hemolytic; Benzofurans; Cardiac Complexes, Premature; Heart Failure; Humans; Mal | 1983 |
[Cordaron therapy of extrasystolic arrhythmia].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Benzofurans; Cardiac Complexes, Premature; Drug Admin | 1983 |
[Detection and long-term treatment of ventricular extrasystole in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Female; Heart Ventricles; Humans; | 1983 |
[Intravenous administration of cordaron in the emergency therapy of ventricular extrasystole in patients with ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Benzofurans; Cardiac Complexes, Premature; Coronary Disease; Emergencies; F | 1983 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cohort Studies; Coronary Disea | 1994 |
Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
Topics: Actuarial Analysis; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden, Cardi | 1994 |
Does ursodeoxycholic acid have a place in the treatment of amiodarone-induced cholestasis?
Topics: Aged; Amiodarone; Cardiac Complexes, Premature; Cholestasis, Intrahepatic; Humans; Male; Ursodeoxych | 1994 |
Amiodarone for patients with ventricular premature depolarizations after myocardial infarction. Is it safe to stop treatment at one year?
Topics: Amiodarone; Cardiac Complexes, Premature; Humans; Myocardial Infarction; Time Factors | 1993 |
[Torsade de pointes during anti-arrhythmia treatment with amiodarone].
Topics: Amiodarone; Cardiac Complexes, Premature; Electrocardiography; Humans; Male; Middle Aged; Torsades d | 1993 |
Amiodarone: should we use it more than we do?
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Death, Sudden, | 1993 |
[Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Drug Evaluation; Humans | 1975 |
[Study of the effectiveness of cordaron in different types of arrhythmia].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Prematu | 1977 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutte | 1978 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
[Combination anti-arrhythmic drug therapy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electro | 1992 |
[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Am | 1990 |
[The characteristics of the chronotropic and anti-arrhythmia effects of kordaron].
Topics: Adolescent; Adult; Amiodarone; Cardiac Complexes, Premature; Cardiomyopathies; Drug Evaluation; Fema | 1990 |
[Optic neuropathy caused by amiodarone].
Topics: Amiodarone; Animals; Cardiac Complexes, Premature; Demyelinating Diseases; Humans; Male; Middle Aged | 1990 |
[Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal].
Topics: Adult; Alcoholism; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Ethanol; Humans | 1991 |
[Long-term treatment with amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Elec | 1991 |
[Effect of amiodarone on signal-averaged and long-term ECG].
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cardi | 1991 |
[Treatment of ventricular arrhythmia resistant to sodium channel blockaders].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Resistance; Huma | 1991 |
[Amidaron-induced dermatopathy resulting from unnecessary Cordarone therapy of ventricular parasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cyanosis; Diagnostic Errors; Drug Er | 1991 |
[The time characteristics of the chronotropic and anti-arrhythmia effects of kordaron].
Topics: Adolescent; Adult; Amiodarone; Cardiac Complexes, Premature; Electrocardiography; Female; Heart Rate | 1991 |
PVCs in the elderly: when to start worrying.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Electrocardio | 1985 |
[Cardiac rhythm disorders after pneumonectomy].
Topics: Adenocarcinoma; Adult; Aged; Aging; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Carcinoma | 1985 |
[Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)].
Topics: Acetanilides; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; | 1985 |
Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature | 1985 |
Delayed ventricular repolarization as an anti-arrhythmic principle.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bund | 1985 |
[Interstitial pneumopathy and amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Humans; Male; Pul | 1986 |
[Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles].
Topics: Adult; Aged; Amiodarone; Benzofurans; Cardiac Complexes, Premature; Disopyramide; Electrocardiograph | 1986 |
Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
Topics: Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; | 1986 |
Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes.
Topics: Administration, Oral; Adult; Amiodarone; Cardiac Complexes, Premature; Electrocardiography; Female; | 1986 |
[Experience in using kordaron in parasystole and extrasystole].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Electrocardiography | 1986 |
[Arrhythmia in patients with a DDD bicameral pacemaker].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Electroc | 1986 |
[Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; T | 1987 |
Clinical value of cordarone as an antiarrhythmic agent.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, P | 1987 |
Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy.
Topics: Amiodarone; Biopsy; Cardiac Complexes, Premature; Cerebellar Diseases; Female; Humans; Middle Aged; | 1987 |
The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dogs; Dose-Response Relatio | 1988 |
Mortality in heart failure: clinical variables of prognostic value.
Topics: Amiodarone; Cardiac Complexes, Premature; Female; Heart Failure; Humans; Male; Middle Aged; Prognosi | 1987 |
[Clinical experiences in the use of amiodarone in the suppression of ventricular premature contractions].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiac Complexes, Premature; Drug Evaluation; Female | 1987 |
[A case of chemical hyperthyroidism induced by antiarrhythmic agent amiodarone].
Topics: Amiodarone; Cardiac Complexes, Premature; Diabetes Complications; Humans; Hyperthyroidism; Male; Mid | 1988 |
[Non-arteriosclerotic myocardial infarction in a 24-year-old patient and unintended use of amiodarone during pregnancy without embryotoxic effects].
Topics: Abnormalities, Drug-Induced; Adult; Amiodarone; Cardiac Complexes, Premature; Coronary Aneurysm; Emb | 1988 |
Neonatal hyperthyroxinaemia associated with maternal amiodarone therapy: case report.
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Female; Humans; Hyperthyroxinemia; Infant, Newborn; | 1988 |
Serum reverse T3 and amiodarone efficacy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Electrocardiography; Femal | 1989 |
[Marked allergic reaction of the skin to amiodarone].
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Drug Eruptions; Female; Humans | 1989 |
[Deglutition-induced supraventricular tachycardias].
Topics: Amiodarone; Atrial Flutter; Bundle of His; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; | 1989 |
[Anti-arrhythmic activity of atropine, ritmilen, obsidan and cordarone in patients with ventricular allorhythmia].
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atropine; Cardiac Compl | 1989 |
[Ventricular fibrillation caused by the combined administration of amiodarone and quinidine].
Topics: Adolescent; Amiodarone; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography | 1989 |
[Pneumonitis induced by amiodarone].
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged | 1989 |
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Pr | 1985 |